Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Sangamo Biosciences, Inc.”

84 pharma patents match "Sangamo Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 84
Index total 30,257
Page 1 / 4

Quick answer

This filtered view shows 84 pharmaceutical patents matching "Sangamo Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

84 results for “Sangamo Biosciences, Inc.” · 30,257 patents in full index Clear search

  1. US 11884930

    Method of inactivating a glucocorticoid receptor gene in an isolated cell

    Sangamo Biosciences, Inc. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  2. US 9650648

    Methods and compositions for treatment of a genetic condition

    Sangamo Biosciences, Inc. · Granted May 16, 2017 · Expires May 11, 2037

    granted
  3. US 9631186

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Sangamo Biosciences, Inc. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  4. US 9631187

    Methods and compositions for gene correction

    Sangamo Biosciences, Inc. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  5. US 9629930

    Methods and compositions for treating hemophilia B

    Sangamo Biosciences, Inc. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  6. US 9624509

    Modulation of stem cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  7. US 9624498

    Methods and compositions for regulation of zinc finger protein expression

    Sangamo Biosciences, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  8. US 9616090

    Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

    Sangamo Biosciences, Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted
  9. US 9597357

    T cell modifying compounds and uses thereof

    Sangamo Biosciences, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  10. US 9574211

    Methods and compositions for prevention or treatment of a disease

    Sangamo Biosciences, Inc. · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted
  11. US 9566352

    Methods and compositions for inhibiting viral entry into cells

    Sangamo Biosciences, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  12. US 9567573

    Genome editing of a Rosa locus using nucleases

    Sangamo Biosciences, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  13. US 9567609

    Compositions for linking DNA-binding domains and cleavage domains

    Sangamo Biosciences, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  14. US 9499597

    Methods and compositions for treating Huntington's disease

    Sangamo Biosciences, Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  15. US 9493750

    DNA-binding proteins and uses thereof

    Sangamo Biosciences, Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  16. US 9491934

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  17. US 9434776

    Methods and compositions for gene inactivation

    Sangamo Biosciences, Inc. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  18. US 9402879

    Methods and compositions for modulating PD1

    Sangamo Biosciences, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  19. US 9394531

    Compositions for linking DNA-binding domains and cleavage domains

    Sangamo Biosciences, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  20. US 9394545

    Methods and compositions for regulation of transgene expression

    Sangamo Biosciences, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  21. US 9322005

    DNA-binding proteins and uses thereof

    Sangamo Biosciences, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  22. US 9289451

    Methods and compositions for targeted cleavage and recombination

    Sangamo Biosciences, Inc. · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted
  23. US 9267154

    Targeted integration into the PPP1R12C locus

    Sangamo Biosciences, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  24. US 9267123

    Methods and compositions for gene correction

    Sangamo Biosciences, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted